Stage IVA Uterine Corpus Cancer

9 clinical trials · Condition

Record	Firm	Date
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners (NCT03112668)	Rutgers, The State University of New Jersey	2017-12-06
Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol (NCT02501954)	Women's Cancer Care Associates, LLC	2015-03-01
Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer (NCT02112552)	Albert Einstein College of Medicine	2014-04-10
Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors (NCT02575872)	Albert Einstein College of Medicine	2013-10-01
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors (NCT01522820)	Roswell Park Cancer Institute	2012-03-01
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (NCT01010126)	National Cancer Institute (NCI)	2009-09-08
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer (NCT01041027)	Albert Einstein College of Medicine	2009-01-16
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer (NCT00729586)	National Cancer Institute (NCI)	2008-09-01
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer (NCT00575952)	Gynecologic Oncology Group	2008-01-17

Track Stage IVA Uterine Corpus Cancer automatically

Every clearance here is in the API, with alerts when new ones post.